ATE463572T1 - Rekombinanter faktor viii mit erhöhter spezifischer aktivität - Google Patents
Rekombinanter faktor viii mit erhöhter spezifischer aktivitätInfo
- Publication number
- ATE463572T1 ATE463572T1 AT04812686T AT04812686T ATE463572T1 AT E463572 T1 ATE463572 T1 AT E463572T1 AT 04812686 T AT04812686 T AT 04812686T AT 04812686 T AT04812686 T AT 04812686T AT E463572 T1 ATE463572 T1 AT E463572T1
- Authority
- AT
- Austria
- Prior art keywords
- factor viii
- recombinant factor
- specific activity
- increased specific
- relates
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52666403P | 2003-12-03 | 2003-12-03 | |
PCT/US2004/040234 WO2005055930A2 (en) | 2003-12-03 | 2004-12-02 | Recombinant factor viii having increased specific activity |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE463572T1 true ATE463572T1 (de) | 2010-04-15 |
Family
ID=34676640
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04812686T ATE463572T1 (de) | 2003-12-03 | 2004-12-02 | Rekombinanter faktor viii mit erhöhter spezifischer aktivität |
Country Status (7)
Country | Link |
---|---|
US (1) | US7855274B2 (de) |
EP (1) | EP1699469B1 (de) |
AT (1) | ATE463572T1 (de) |
AU (1) | AU2004296768B2 (de) |
CA (1) | CA2547569C (de) |
DE (1) | DE602004026474D1 (de) |
WO (1) | WO2005055930A2 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL1824988T3 (pl) | 2004-11-12 | 2018-01-31 | Bayer Healthcare Llc | Ukierunkowana na miejsce modyfikacja czynnika VIII |
WO2007011746A2 (en) | 2005-07-15 | 2007-01-25 | The University Of Vermont And State Agriculture College | Highly sensitive immunoassays and antibodies for detection of blood factor viii |
WO2008048705A2 (en) | 2006-03-10 | 2008-04-24 | Goodrich Corporation | Low density lightning strike protection for use in airplanes |
WO2009058446A1 (en) * | 2007-11-01 | 2009-05-07 | University Of Rochester | Recombinant factor viii having increased stability |
UA112050C2 (uk) * | 2008-08-04 | 2016-07-25 | БАЄР ХЕЛСКЕР ЛЛСі | Терапевтична композиція, що містить моноклональне антитіло проти інгібітора шляху тканинного фактора (tfpi) |
SG10201502587SA (en) | 2010-03-01 | 2015-06-29 | Bayer Healthcare Llc | Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi) |
US8637448B2 (en) * | 2010-09-14 | 2014-01-28 | University Of Rochester | Recombinant factor VIII having enhanced stability following mutation at the A1-C2 domain interface |
PT3013855T (pt) * | 2013-06-24 | 2021-01-13 | Weidong Xiao | Composições de fator viii mutante e métodos |
KR102450833B1 (ko) | 2016-04-15 | 2022-10-05 | 더 트러스티스 오브 더 유니버시티 오브 펜실베니아 | 혈우병 a 치료용 유전자 요법 |
US11471497B1 (en) | 2019-03-13 | 2022-10-18 | David Gordon Bermudes | Copper chelation therapeutics |
CN111651033B (zh) * | 2019-06-26 | 2024-03-05 | 广州虎牙科技有限公司 | 一种人脸的驱动显示方法、装置、电子设备和存储介质 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5422260A (en) * | 1986-05-29 | 1995-06-06 | Genetics Institute, Inc. -Legal Affairs | Human factor VIII:c muteins |
US5859204A (en) * | 1992-04-07 | 1999-01-12 | Emory University | Modified factor VIII |
US6376463B1 (en) | 1992-04-07 | 2002-04-23 | Emory University | Modified factor VIII |
US5576291A (en) | 1993-09-13 | 1996-11-19 | Baxter International Inc. | Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency |
US5880327A (en) | 1994-09-21 | 1999-03-09 | American National Red Cross | Transgenic mammals expressing human coagulation factor VIII |
US20040092442A1 (en) | 1996-04-24 | 2004-05-13 | University Of Michigan | Inactivation resistant factor VIII |
US6458563B1 (en) | 1996-06-26 | 2002-10-01 | Emory University | Modified factor VIII |
US6593291B1 (en) | 1997-02-06 | 2003-07-15 | Entremed, Inc. | Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
US5994310A (en) | 1998-09-03 | 1999-11-30 | Bayer Corporation | Peptide ligands for affinity purification of human Factor VIII |
US6759216B1 (en) * | 1998-11-06 | 2004-07-06 | Emory University | Glycosylated, low antigenicity low immunogenicity factor VIII |
EP1038959A1 (de) | 1999-03-17 | 2000-09-27 | Aventis Behring Gesellschaft mit beschränkter Haftung | Faktor VIII ohne B-Domän, der ein oder mehrere Insertionsstücke von verkürztem Intron I des Faktors IX enthält |
ES2252028T3 (es) | 1999-07-13 | 2006-05-16 | Biovitrum Ab | Composiciones estables del factor viii. |
US7771929B2 (en) * | 2000-04-28 | 2010-08-10 | Monogram Biosciences, Inc. | Tag library compounds, compositions, kits and methods of use |
PL206105B1 (pl) | 2000-09-19 | 2010-07-30 | Emory Universityemory University | Zmodyfikowany ludzki czynnik VIII oraz sposób modyfikacji ludzkiego czynnika VIII ze zmniejszeniem reaktywności na przeciwciało hamujące i zachowaniem aktywności prokoagulacyjnej |
EP1233064A1 (de) | 2001-02-09 | 2002-08-21 | Aventis Behring Gesellschaft mit beschränkter Haftung | Modifizierte Faktor VIII cDNA und deren Verwendung bei der Produktion von Faktor VIII |
US7205278B2 (en) | 2001-06-14 | 2007-04-17 | The Scripps Research Institute | Stabilized proteins with engineered disulfide bonds |
EP1424344A1 (de) | 2002-11-29 | 2004-06-02 | Aventis Behring Gesellschaft mit beschränkter Haftung | Modifizierte cDNA des Factors VIII und Derivate davon |
US7041635B2 (en) | 2003-01-28 | 2006-05-09 | In2Gen Co., Ltd. | Factor VIII polypeptide |
US7211559B2 (en) * | 2003-10-31 | 2007-05-01 | University Of Maryland, Baltimore | Factor VIII compositions and methods |
-
2004
- 2004-12-02 EP EP04812686A patent/EP1699469B1/de not_active Not-in-force
- 2004-12-02 DE DE602004026474T patent/DE602004026474D1/de active Active
- 2004-12-02 AT AT04812686T patent/ATE463572T1/de not_active IP Right Cessation
- 2004-12-02 AU AU2004296768A patent/AU2004296768B2/en not_active Ceased
- 2004-12-02 WO PCT/US2004/040234 patent/WO2005055930A2/en active Application Filing
- 2004-12-02 CA CA2547569A patent/CA2547569C/en not_active Expired - Fee Related
- 2004-12-02 US US10/581,471 patent/US7855274B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2004296768B2 (en) | 2010-06-24 |
DE602004026474D1 (de) | 2010-05-20 |
CA2547569A1 (en) | 2005-06-23 |
US20070265199A1 (en) | 2007-11-15 |
WO2005055930A3 (en) | 2005-08-18 |
AU2004296768A1 (en) | 2005-06-23 |
EP1699469A4 (de) | 2007-01-24 |
US7855274B2 (en) | 2010-12-21 |
EP1699469B1 (de) | 2010-04-07 |
EP1699469A2 (de) | 2006-09-13 |
WO2005055930A2 (en) | 2005-06-23 |
CA2547569C (en) | 2013-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20042570L (no) | Antimikrobielle polypeptider fra Pseudoplectania nigrella | |
WO2004056981A3 (en) | Polypeptides having cellobiohydrolase ii activity and polynucleotides encoding same | |
MX2007007862A (es) | Proteasas fungales acidas. | |
WO2003000941A3 (en) | Polypeptides having cellobiohydrolase i activity and polynucleotides encoding same | |
WO2002095014A3 (en) | Polypeptides having cellobiase activity and polynucleotides encoding same | |
DK1266011T3 (da) | Svampetranskriptionsaktivator, der er anvendelig i fremgangsmåder til fremstilling af polypeptider | |
EP2287178A3 (de) | Bacillus licheniformis YvmC-Deaktivierung | |
BR9814404A (pt) | " clonagem de expressão em fungos filamentosos " | |
EA201070764A1 (ru) | Полипептиды, обладающие активностью, усиливающей лизис целлюлозы, и кодирующие их полинуклеотиды | |
WO2010059413A3 (en) | Polypeptides having amylolytic enhancing activity and polynucleotides encoding same | |
DE602004021836D1 (de) | Meg1-endospermspezifische promotoren und gene | |
WO2002086144A3 (en) | Compositions and methods for recombinational cloning of nucleic acid molecules | |
ATE463572T1 (de) | Rekombinanter faktor viii mit erhöhter spezifischer aktivität | |
EA200700233A1 (ru) | Новая последовательность для повышения экспрессии нуклеиновой кислоты | |
DK1877551T4 (da) | Polypeptider, der har endoglucanaseaktivitet, og polynukleotider, der koder for samme | |
DK1117798T3 (da) | Fungal transskriptionel aktivator egnet ved fremgangsmåder til produktion af polypeptider | |
WO2006005032A3 (en) | Polypeptides having alpha-glucosidase activity and polynucleotides encoding same | |
WO2003106674A3 (en) | MEANS AND METHODS FOR REGULATING GENE EXPRESSION | |
EA200401531A1 (ru) | Новые фосфолипазы и их применение | |
DK0981631T3 (da) | Polypeptider, som har aminopeptidase-aktivitet, og nukleinsyrer, som koder for samme | |
NO20034692D0 (no) | Nye polynukleotider og polypeptider av IFN gamma-17 genet | |
ATE542913T1 (de) | Promotorvarianten zur expression von genen in einer pilzzelle | |
ATE445009T1 (de) | Signalpeptid zur herstellung eines polypeptids | |
WO2006014490A3 (en) | Polypeptides having alpha-glucosidase activity and polynucleotides encoding same | |
DE60040077D1 (de) | Vermehrungsproteine von pflanzen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |